Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 3
1979 2
1980 2
1982 2
1983 1
1984 2
1991 1
1994 3
1995 4
1996 3
1997 4
1998 7
1999 7
2000 11
2001 9
2002 12
2003 10
2004 11
2005 9
2006 10
2007 11
2008 14
2009 13
2010 13
2011 19
2012 24
2013 16
2014 16
2015 15
2016 18
2017 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

246 results
Results by year
Filters applied: . Clear all
Page 1
Clinically available pharmacogenomics tests.
Flockhart DA, Skaar T, Berlin DS, Klein TE, Nguyen AT. Flockhart DA, et al. Clin Pharmacol Ther. 2009 Jul;86(1):109-13. doi: 10.1038/clpt.2009.39. Epub 2009 Apr 15. Clin Pharmacol Ther. 2009. PMID: 19369936 Free PMC article. Review.
Is personalized medicine achievable in obstetrics?
Quinney SK, Patil AS, Flockhart DA. Quinney SK, et al. Among authors: flockhart da. Semin Perinatol. 2014 Dec;38(8):534-40. doi: 10.1053/j.semperi.2014.08.017. Epub 2014 Oct 3. Semin Perinatol. 2014. PMID: 25282474 Free PMC article. Review.
PharmGKB summary: tamoxifen pathway, pharmacokinetics.
Klein DJ, Thorn CF, Desta Z, Flockhart DA, Altman RB, Klein TE. Klein DJ, et al. Among authors: flockhart da. Pharmacogenet Genomics. 2013 Nov;23(11):643-7. doi: 10.1097/FPC.0b013e3283656bc1. Pharmacogenet Genomics. 2013. PMID: 23962908 Free PMC article. Review. No abstract available.
Pharmacogenomics: challenges and opportunities.
Roden DM, Altman RB, Benowitz NL, Flockhart DA, Giacomini KM, Johnson JA, Krauss RM, McLeod HL, Ratain MJ, Relling MV, Ring HZ, Shuldiner AR, Weinshilboum RM, Weiss ST; Pharmacogenetics Research Network. Roden DM, et al. Among authors: flockhart da. Ann Intern Med. 2006 Nov 21;145(10):749-57. doi: 10.7326/0003-4819-145-10-200611210-00007. Ann Intern Med. 2006. PMID: 17116919 Free PMC article. Review.
Clinical pharmacology. Blue-chip technology.
Flockhart DA, Webb DJ. Flockhart DA, et al. Lancet. 1998 Dec 19-26;352 Suppl 4:SIV2. Lancet. 1998. PMID: 9872149 Free article. Review. No abstract available.
Olanzapine-induced rhabdomyolysis.
Rosebraugh CJ, Flockhart DA, Yasuda SU, Woosley RL. Rosebraugh CJ, et al. Among authors: flockhart da. Ann Pharmacother. 2001 Sep;35(9):1020-3. doi: 10.1345/aph.10370. Ann Pharmacother. 2001. PMID: 11573848
Cytochrome P450-mediated drug interactions.
Flockhart DA, Oesterheld JR. Flockhart DA, et al. Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):43-76. Child Adolesc Psychiatr Clin N Am. 2000. PMID: 10674190 Review.
Pharmacogenetics in the treatment of breast cancer.
Stearns V, Davidson NE, Flockhart DA. Stearns V, et al. Among authors: flockhart da. Pharmacogenomics J. 2004;4(3):143-53. doi: 10.1038/sj.tpj.6500242. Pharmacogenomics J. 2004. PMID: 15024382 Review. No abstract available.
Implementation of a pharmacogenomics consult service to support the INGENIOUS trial.
Eadon MT, Desta Z, Levy KD, Decker BS, Pierson RC, Pratt VM, Callaghan JT, Rosenman MB, Carpenter JS, Holmes AM, McDonald CA, Benson EA, Patil AS, Vuppalanchi R, Gufford BT, Dave N, Robarge JD, Hyder MA, Haas DM, Kreutz RP, Dexter PR, Skaar TC, Flockhart DA. Eadon MT, et al. Among authors: flockhart da. Clin Pharmacol Ther. 2016 Jul;100(1):63-6. doi: 10.1002/cpt.347. Epub 2016 Mar 31. Clin Pharmacol Ther. 2016. PMID: 26850569 Free PMC article. Review.
246 results